Comparison between Molbio Diagnostics IPO and UKB Electronics IPO.
Molbio Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while UKB Electronics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Molbio Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the UKB Electronics IPO is up to ₹800.00 Cr. The final issue price of Molbio Diagnostics IPO is and of UKB Electronics IPO is .
| Molbio Diagnostics IPO | UKB Electronics IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹200.00 Cr | up to ₹400.00 Cr |
| OFS Issue Size | 1,25,56,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹400.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹800.00 Cr |
Molbio Diagnostics IPO opens on , while UKB Electronics IPO opens on . The closing date of Molbio Diagnostics IPO and UKB Electronics IPO is , and , respectively.
Molbio Diagnostics IPO P/E ratio is , as compared to UKB Electronics IPO P/E ratio of .
| Molbio Diagnostics IPO | UKB Electronics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Molbio Diagnostics Ltd.'s revenue increased by 22% and profit after tax (PAT) rose by 66% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)UKB Electronics Ltd.'s revenue increased by 33% and profit after tax (PAT) rose by 72% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 46.65 | 99.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 16.20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.98% | 27.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.29 | ₹1.56 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.23% | 22.52% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Molbio Diagnostics IPO Retail Individual Investors (RII) are offered 0 shares while in UKB Electronics IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Molbio Diagnostics IPO and 0 shares in UKB Electronics IPO.
| Molbio Diagnostics IPO | UKB Electronics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Molbio Diagnostics IPO subscribed in total, whereas UKB Electronics IPO subscribed .
